Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Polarityte Inc's Business Segments
Polarityte Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2022
Reportable Segments
2
Largest Segment
Contract Services
Total Revenue
$ 1
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2022
- Contract Services100%
- Regenerative Medicine0%
Revenue by Reportable Segment - Q1 FY2022
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Contract Services | $ 1 | 100% |
| Regenerative Medicine | - | 0% |
Revenue by Product & Service Category - Q1 FY2022
- Service100%
Revenue by Product & Service Category - Q1 FY2022
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Service | $ 1 | 100% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Polarityte Inc
Polarityte Inc is a biotechnology company focused on regenerative medicine. The company was founded in 2004 and is headquartered in Salt Lake City, Utah, United States.
Polarityte aims to address the significant unmet medical needs in the field of regenerative medicine by developing and commercializing innovative products. The company's flagship product is the SkinTE, a human cellular and tissue-based product that is designed to regenerate full-thickness, functional skin for the treatment of various skin defects and wounds.
SkinTE is created using the company's patented platform technology, which allows for the self-assembly of skin-like tissue in a laboratory setting. The product is developed by obtaining a small sample of the patient's own skin, isolating the skin's cells, and then processing them to form a three-dimensional tissue construct. This construct is then placed onto the patient's wound, where it integrates with the surrounding tissue, promoting healing and regeneration.
Polarityte's technology is based on the principles of cell biology, tissue engineering, and biomaterial sciences. The company's platform technology enables the production of fully functioning tissues that mimic the structure and function of native tissues. This approach has the potential to revolutionize the field of regenerative medicine by providing personalized, patient-specific treatments for a wide range of conditions.
In addition to SkinTE, Polarityte is also developing other regenerative medicine products for the treatment of various diseases and conditions. The company's pipeline includes products for the regeneration of bones, cartilage, blood vessels, and nerves.
Polarityte Inc is actively engaged in clinical trials to evaluate the safety and efficacy of its products. The company has collaborated with leading academic and research institutions to conduct these trials. Additionally, Polarityte has received regulatory approvals for the commercialization of SkinTE in the United States and is working towards expanding its market presence globally.
As a biotechnology company, Polarityte is focused on advancing the field of regenerative medicine and transforming the way we approach the treatment of various diseases and injuries. The company's innovative platform technology and commitment to scientific research make it a promising player in the biotech industry.
Polarityte aims to address the significant unmet medical needs in the field of regenerative medicine by developing and commercializing innovative products. The company's flagship product is the SkinTE, a human cellular and tissue-based product that is designed to regenerate full-thickness, functional skin for the treatment of various skin defects and wounds.
SkinTE is created using the company's patented platform technology, which allows for the self-assembly of skin-like tissue in a laboratory setting. The product is developed by obtaining a small sample of the patient's own skin, isolating the skin's cells, and then processing them to form a three-dimensional tissue construct. This construct is then placed onto the patient's wound, where it integrates with the surrounding tissue, promoting healing and regeneration.
Polarityte's technology is based on the principles of cell biology, tissue engineering, and biomaterial sciences. The company's platform technology enables the production of fully functioning tissues that mimic the structure and function of native tissues. This approach has the potential to revolutionize the field of regenerative medicine by providing personalized, patient-specific treatments for a wide range of conditions.
In addition to SkinTE, Polarityte is also developing other regenerative medicine products for the treatment of various diseases and conditions. The company's pipeline includes products for the regeneration of bones, cartilage, blood vessels, and nerves.
Polarityte Inc is actively engaged in clinical trials to evaluate the safety and efficacy of its products. The company has collaborated with leading academic and research institutions to conduct these trials. Additionally, Polarityte has received regulatory approvals for the commercialization of SkinTE in the United States and is working towards expanding its market presence globally.
As a biotechnology company, Polarityte is focused on advancing the field of regenerative medicine and transforming the way we approach the treatment of various diseases and injuries. The company's innovative platform technology and commitment to scientific research make it a promising player in the biotech industry.
Polarityte Inc. is an innovative biotechnology company focused on advancing the field of regenerative medicine through the development and commercialization of cutting-edge tissue products. Utilizing its proprietary PolarityTE platform, the company aims to transform tissue regeneration methodologies and enhance patient outcomes across various medical applications.
Segments
Polarityte operates primarily within the healthcare industry, with a concentration on regenerative medicine. The following are key segments within this landscape where the company is making significant strides:
1. Regenerative Tissue Engineering: This segment focuses on the design and development of bioengineered tissues that can replicate the structure and function of human tissues, addressing critical medical needs in wound healing, bone and cartilage repair.
2. Wound Care Management: By providing advanced solutions for the treatment of complex wounds, Polarityte is addressing an urgent need in both acute and chronic care settings.
3. Orthopedic and Spine Surgery: Through its innovative bone and cartilage regeneration products, Polarityte aims to enhance surgical outcomes and reduce the complications often associated with traditional grafting techniques.
4. Dermatological Applications: The company also targets a range of dermatological conditions, providing effective solutions for skin restoration and reconstruction, which can significantly improve quality of life for patients.
Products
Polarityte offers a suite of biologically based products designed to leverage the bodys natural healing processes. The key products include:
1. SkinTE: This flagship product represents a significant advancement in wound care. SkinTE is a complete autologous human cellular and tissue-based product designed to provide full-thickness, functional skin. It activates the bodys innate healing mechanisms, making it suitable for a range of applications including:
- Treatment of acute wounds, such as surgical or traumatic wounds.
- Chronic wound management in conditions like diabetic ulcers and venous stasis ulcers.
- Burns requiring skin restoration.
- Reconstructive surgeries involving complex dermatological conditions.
2. OsteoTE: A revolutionary tissue-engineered solution for bone regeneration, OsteoTE serves as a substitute for traditional autologous bone grafts. It is versatile enough for use in various surgical procedures, including orthopedic and spinal surgeries. OsteoTE addresses the challenges associated with donor site morbidity and graft rejection, offering a safer and more effective option for bone repair.
3. CartTE: Targeted at promoting cartilage regeneration, CartTE utilizes a patient-specific approach to enhance recovery from osteochondral defects and cartilage injuries. This products personalized aspect makes it particularly innovative, potentially leading to improved longevity and efficacy in treatment outcomes, setting it apart from conventional cartilage repair methods.
Services
Polarityte complements its product offerings with a range of essential services aimed at ensuring optimal utilization of its technologies:
1. Contract Research and Development: Polarityte engages in partnerships to tailor regenerative therapies that address specific clinical needs. This service leverages its expertise in tissue engineering, enabling the development of novel treatments responsive to evolving medical requirements.
2. Training and Education: To foster the effective application of its regenerative solutions, Polarityte provides educational programs for healthcare professionals. These initiatives focus on best practices and recent advancements in regenerative medicine, ensuring that practitioners are well-equipped to utilize the products effectively.
3. Clinical Support and Consulting: The company extends support to healthcare providers through consulting services that guide the application of Polarityte products in clinical settings. This ensures practitioners can navigate the complexities of regenerative medicine and maximize patient outcomes.
Conclusion
Polarityte Inc. is deeply committed to enhancing the standards of care within regenerative medicine. Through its innovative products and comprehensive services, the company aims to redefine approaches to tissue repair and regeneration, ultimately improving patient outcomes and contributing to the advancement of the healthcare field. By harnessing the body’s intrinsic regenerative capabilities, Polarityte positions itself as a key player in the evolution of treatment strategies across various medical disciplines.
Segments
Polarityte operates primarily within the healthcare industry, with a concentration on regenerative medicine. The following are key segments within this landscape where the company is making significant strides:
1. Regenerative Tissue Engineering: This segment focuses on the design and development of bioengineered tissues that can replicate the structure and function of human tissues, addressing critical medical needs in wound healing, bone and cartilage repair.
2. Wound Care Management: By providing advanced solutions for the treatment of complex wounds, Polarityte is addressing an urgent need in both acute and chronic care settings.
3. Orthopedic and Spine Surgery: Through its innovative bone and cartilage regeneration products, Polarityte aims to enhance surgical outcomes and reduce the complications often associated with traditional grafting techniques.
4. Dermatological Applications: The company also targets a range of dermatological conditions, providing effective solutions for skin restoration and reconstruction, which can significantly improve quality of life for patients.
Products
Polarityte offers a suite of biologically based products designed to leverage the bodys natural healing processes. The key products include:
1. SkinTE: This flagship product represents a significant advancement in wound care. SkinTE is a complete autologous human cellular and tissue-based product designed to provide full-thickness, functional skin. It activates the bodys innate healing mechanisms, making it suitable for a range of applications including:
- Treatment of acute wounds, such as surgical or traumatic wounds.
- Chronic wound management in conditions like diabetic ulcers and venous stasis ulcers.
- Burns requiring skin restoration.
- Reconstructive surgeries involving complex dermatological conditions.
2. OsteoTE: A revolutionary tissue-engineered solution for bone regeneration, OsteoTE serves as a substitute for traditional autologous bone grafts. It is versatile enough for use in various surgical procedures, including orthopedic and spinal surgeries. OsteoTE addresses the challenges associated with donor site morbidity and graft rejection, offering a safer and more effective option for bone repair.
3. CartTE: Targeted at promoting cartilage regeneration, CartTE utilizes a patient-specific approach to enhance recovery from osteochondral defects and cartilage injuries. This products personalized aspect makes it particularly innovative, potentially leading to improved longevity and efficacy in treatment outcomes, setting it apart from conventional cartilage repair methods.
Services
Polarityte complements its product offerings with a range of essential services aimed at ensuring optimal utilization of its technologies:
1. Contract Research and Development: Polarityte engages in partnerships to tailor regenerative therapies that address specific clinical needs. This service leverages its expertise in tissue engineering, enabling the development of novel treatments responsive to evolving medical requirements.
2. Training and Education: To foster the effective application of its regenerative solutions, Polarityte provides educational programs for healthcare professionals. These initiatives focus on best practices and recent advancements in regenerative medicine, ensuring that practitioners are well-equipped to utilize the products effectively.
3. Clinical Support and Consulting: The company extends support to healthcare providers through consulting services that guide the application of Polarityte products in clinical settings. This ensures practitioners can navigate the complexities of regenerative medicine and maximize patient outcomes.
Conclusion
Polarityte Inc. is deeply committed to enhancing the standards of care within regenerative medicine. Through its innovative products and comprehensive services, the company aims to redefine approaches to tissue repair and regeneration, ultimately improving patient outcomes and contributing to the advancement of the healthcare field. By harnessing the body’s intrinsic regenerative capabilities, Polarityte positions itself as a key player in the evolution of treatment strategies across various medical disciplines.